Interventions to Improving Osteoporosis Screening: An Iowa Research Network (IRENE) Study

References

1. ↵
   Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 2001; 286: 2815–22.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Mussolino ME, Madans JH, Gillum RF. Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study. Ann Epidemiol 2003; 13: 692–7.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   Wehren LE, Siris ES. Beyond bone mineral density: can existing clinical risk assessment instruments identify women at increased risk of osteoporosis? J Intern Med 2004; 256: 375–80.

   OpenUrlCrossRefPubMed
4. Cadarette SM, McIsaac WJ, Hawker GA, et al. The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing. Osteoporos Int 2004; 15: 361–6.

   OpenUrlCrossRefPubMedWeb of Science
5. Wildner M, Peters A, Raghuvanshi VS, Hohnloser J, Siebert U. Superiority of age and weight as variables in predicting osteoporosis in postmenopausal white women. Osteoporos Int 2003; 14: 950–6.

   OpenUrlPubMed
6. ↵
   National Osteoporosis Foundation. Pocket guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 1999.
7. ↵
   Solomon DH, Brookhart MA, Gandhi TK, et al. Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med 2004; 117: 919–24.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   Gill JM, Hoffman MK. Prevention and treatment of osteoporosis in primary care offices. J Womens Health (Larchmt) 2003; 12: 473–80.

   OpenUrlPubMed
9. ↵
   Weiss TW, Siris ES, Barrett-Connor E, Miller PD, McHorney CA. Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study. Osteoporos Int 2007; 18: 1473–80.

   OpenUrlPubMed
10. ↵
    King AB, Saag KG, Burge RT, Pisu M, Goel N. Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment. Osteoporos Int 2005; 16: 1545–57.

    OpenUrlCrossRefPubMed
11. ↵
    Lafata JE, Kolk D, Peterson EL, et al. Improving osteoporosis screening: results from a randomized cluster trial. J Gen Intern Med 2007; 22: 346–51.

    OpenUrlCrossRefPubMed
12. ↵
    Solomon DH, Katz JN, Finkelstein JS, et al. Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res 2007; 22: 1808–15.

    OpenUrlCrossRefPubMed
13. ↵
    Stock JL, Waud CE, Coderre JA, et al. Clinical reporting to primary care physicians leads to increased use and understanding of bone densitometry and affects the management of osteoporosis. A randomized trial. Ann Intern Med 1998; 128: 996–9.

    OpenUrlPubMedWeb of Science
14. ↵
    Wroe AL, Salkovskis PM, Rimes KA. The effect of nondirective questioning on women's decisions whether to undergo bone density screening: an experimental study. Health Psychol 2000; 19: 181–91.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002; 136: 641–51.

    OpenUrlPubMedWeb of Science
16. ↵
    Balas EA, Weingarten S, Garb CT, Blumenthal D, Boren SA, Brown GD. Improving preventive care by prompting physicians. Arch Intern Med 2000; 160: 301–8.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    Glasgow RE, Orleans CT, Wagner EH. Does the chronic care model serve also as a template for improving prevention? Milbank Q 2001; 79: 579–612, iv-v.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 2004; 39: 1005–26.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    Hollon MF. Direct-to-consumer advertising: a haphazard approach to health promotion. JAMA 2005; 293: 2030–3.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    Kravitz RL, Epstein RM, Feldman MD, et al. Influence of patients’ requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 2005; 293: 1995–2002.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    Levy BT, Dawson J, Hartz AJ, James PA. Colorectal cancer testing among patients cared for by Iowa family physicians. Am J Prev Med 2006; 31: 193–201.

    OpenUrlCrossRefPubMedWeb of Science
22. ↵
    Oliver A. The Veterans Health Administration: an American success story? Milbank Q 2007; 85: 5–35.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    Hung DY, Rundall TG, Tallia AF, Cohen DJ, Halpin HA, Crabtree BF. Rethinking prevention in primary care: applying the chronic care model to address health risk behaviors. Milbank Q 2007; 85: 69–91.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    Westfall JM, Mold J, Fagnan L. Practice-based research–“blue highways” on the NIH roadmap. JAMA 2007; 297: 403–6.

    OpenUrlCrossRefPubMedWeb of Science
25. ↵
    Chatterjee S, Hadi AS. Sensitivity analysis in linear regression, 1st ed. New York, NY: John Wiley & Sons, Inc.; 1988.
26. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994; 3: 95–104.

    OpenUrlCrossRefPubMedWeb of Science
27. Saltelli A, Chan K, Scott EM. Sensitivity analysis, 1st ed. New York, NY: John Wiley and Sons, Inc.; 2000.
28. ↵
    Donner A, Klar N. Pitfalls of and controversies in cluster randomization trials. Am J Public Health 2004; 94: 416–22.

    OpenUrlPubMedWeb of Science
29. ↵
    Murray DM, Varnell SP, Blitstein JL. Design and analysis of group-randomized trials: a review of recent methodological developments. Am J Public Health 2004; 94: 423–32.

    OpenUrlCrossRefPubMedWeb of Science